Overview: The Hepatitis C drugs market Report was valued USD 18700 million and expected to reach USD 281.55 million by the end of forecasting period reflecting a sluggish CAGR of 1.17% by 2030. However, the market has several drawbacks like restraints from regulatory boards, herbal treatment in developing countries that comes at a negligible cost, the self-imitating nature of this...